iScience
Volume 24, Issue 1, 22 January 2021, 101989
Journal home page for iScience

Article
Brd2/4 and Myc regulate alternative cell lineage programmes during early osteoclast differentiation in vitro

https://doi.org/10.1016/j.isci.2020.101989Get rights and content
Under a Creative Commons license
open access

Highlights

  • Upregulation of osteoclast lineage commitment TFs occurs <24hr after RANKL stimulation

  • Enhanced binding of Brd2&4, but not Brd3, is required for osteoclast fate commitment

  • Brd2&4 occupancy is associated with super-enhancer reprogramming and TF rewiring

  • Myc is the epicenter of the TF regulatory network driving osteoclastogenesis

Summary

Osteoclast (OC) development in response to nuclear factor kappa-Β ligand (RANKL) is critical for bone homeostasis in health and in disease. The early and direct chromatin regulatory changes imparted by the BET chromatin readers Brd2-4 and OC-affiliated transcription factors (TFs) during osteoclastogenesis are not known. Here, we demonstrate that in response to RANKL, early OC development entails regulation of two alternative cell fate transcriptional programmes, OC vs macrophage, with repression of the latter following activation of the former. Both programmes are regulated in a non-redundant manner by increased chromatin binding of Brd2 at promoters and of Brd4 at enhancers/super-enhancers. Myc, the top RANKL-induced TF, regulates OC development in co-operation with Brd2/4 and Max and by establishing negative and positive regulatory loops with other lineage-affiliated TFs. These insights into the transcriptional regulation of osteoclastogenesis suggest the clinical potential of selective targeting of Brd2/4 to abrogate pathological OC activation.

Subject areas

Biological Sciences
Developmental Biology
Bioinformatics
Omics
Transcriptomics

Cited by (0)

4

These authors contributed equally

5

Senior author

6

Lead contact